Future Vision II Acquisition Corp. (FVN) Company Overview

KY | Financial Services | Shell Companies | NASDAQ

What does Future Vision II Acquisition Corp. do?

Future Vision II Acquisition Corp. is a Nasdaq-listed blank-check company rather than a conventional operating business. Its ordinary shares trade under FVN, and its purpose is to identify, negotiate and complete an initial business combination. That distinction is fundamental: the company currently has no operating revenue, no customer base and no reportable product business. Its economic substance is a pool of cash and marketable securities held in trust, a sponsor-led acquisition process, redemption rights for public shareholders and a finite deadline to close a transaction.

$61.8M
Marketable securities in trust, March 31, 2026
5.75M
Public shares subject to redemption, March 31, 2026
$0
Operating revenue through March 31, 2026
Sep. 13
Current 2026 outside liquidation deadline

Why the SPAC structure changes the analysis

For an industrial, software or consumer company, analysts normally begin with demand, pricing, margins and free cash flow. For FVN, the starting point is different. The relevant assets are the trust account and contractual rights; the key “product” is access to a proposed transaction; and the central risk is whether the merger closes before the deadline. The latest Form 10-Q for March 31, 2026 states that the company remains a single operating segment and has not begun revenue-producing operations.

Why it matters
FVN should be analyzed as a transaction vehicle. Until a merger closes, conventional revenue multiples, EBITDA margins and terminal-growth assumptions do not describe the listed entity.

How does FVN make money before a merger?

The company’s pre-combination income comes almost entirely from interest and investment income on securities held in trust. That is non-operating income, not evidence of a commercial business model. In the first quarter of 2026, FVN reported $535,511 of income from marketable securities in the trust account and $4,448 of interest on bank balances. Against that, it incurred $121,203 of operating expenses, producing net income of $418,756 for the three months ended March 31, 2026.

IPO capital
$57.5M gross public-unit proceeds, September 2024
Trust assets
$61.8M at March 31, 2026 after investment income and extension deposits
Pre-deal income
$535,511 trust income in Q1 2026
Outcome
Merger funding or redemption cash, depending on shareholder choice and closing

What is the trust account worth per public share?

Dividing the March 31, 2026 trust balance of $61,762,576 by 5,750,000 redeemable public shares gives an implied trust value of about $10.74 per public share before later extension contributions, permitted withdrawals, taxes and transaction adjustments. This is a useful reference point, but it is not a guaranteed trading price. The final redemption amount depends on the trust balance at the applicable redemption date and the number of public shares then outstanding.

$10.74Approximate trust value per redeemable public share at March 31, 2026, calculated from disclosed trust assets divided by 5.75 million public shares.

Why reported net income can be misleading

FVN’s positive net income is primarily a yield on restricted assets. It does not demonstrate customer demand or an operating margin. The 2025 Form 10-K reported $2.07 million of net income, including $2.43 million of trust-account income and $31,606 of bank interest, offset by $391,049 of operating expenses. The correct interpretation is that interest income exceeded corporate and transaction costs during the period—not that FVN had a profitable operating franchise.

What does the latest quarter show?

$62.7M
Total assets, March 31, 2026
$873,737
Operating cash, March 31, 2026
$558,479
Working capital, March 31, 2026
$418,756
Net income, Q1 2026
Metric Q1 2026 / March 31, 2026 Comparison Interpretation
Trust securities $61.76M $61.04M at Dec. 31, 2025 Restricted capital increased through income and extension funding.
Operating cash $0.87M $1.02M at Dec. 31, 2025 Cash outside trust declined as corporate costs continued.
Operating expenses $121,203 $166,900 in Q1 2025 Lower year over year, but still consumes non-trust liquidity.
Net cash used in operations $150,972 Q1 2026 The operating entity remains cash-consuming despite positive accounting income.
Current liabilities $379,475 $158,000 at Dec. 31, 2025 Related-party balances and extension financing increased.

How should the balance sheet be read?

Almost 98.5% of total assets at March 31, 2026 were marketable securities in trust. That concentration is expected for a SPAC and creates a very different liquidity picture from an ordinary corporation. The $61.76 million trust balance is generally unavailable for routine expenses before a business combination; operating needs must be covered by cash outside trust, sponsor support or permitted financing. The company disclosed $188,000 due to a related party and a $191,475 related-party promissory note at quarter-end.

Asset composition — March 31, 2026
Trust securities — $61.76M — 98.5%
Operating cash — $0.87M — 1.4%
Prepaid expenses — $0.06M — 0.1%
Takeaway: nearly all reported assets are restricted trust assets rather than freely deployable operating liquidity.

Which strategic turning points define FVN today?

FVN’s history is short, but the sequence of capital formation, failed deal execution and a replacement merger proposal explains the current risk profile better than a conventional corporate timeline.

  1. January 2024
    The Cayman Islands company was incorporated, creating the acquisition vehicle.
  2. February 2024
    Sponsor HWei Super Speed Co. Ltd. purchased 1,437,500 founder shares for $25,000, establishing sponsor control and incentive exposure.
  3. September 2024
    FVN completed a 5,750,000-unit IPO including the over-allotment, raising $57.5 million of gross public proceeds.
  4. November 2024
    The company agreed to merge with VIWO Technology at a stated $100 million valuation.
  5. December 2025
    The VIWO agreement was terminated after the outside closing date passed, demonstrating execution and timing risk.
  6. January 2026
    FVN signed a new merger agreement with MicroTouch Technology, valuing the target at a $90 million enterprise value.
  7. March–May 2026
    Monthly extensions were funded at $191,475 each, extending the transaction window while increasing sponsor financing exposure.
  8. May 2026
    Nasdaq notified FVN that it did not satisfy the 300 round-lot-holder requirement, adding listing-compliance risk.

What did the failed VIWO transaction change?

The terminated VIWO deal is not simply historical trivia. It shows that signing a merger agreement does not ensure completion. The original agreement contemplated 9,950,250 consideration shares, a $100 million valuation and approximately 54.89% ownership for former VIWO securityholders. When the outside date expired on November 28, 2025, VIWO terminated the agreement on December 29, 2025. That outcome increases the relevance of diligence, financing, regulatory review and calendar risk in evaluating the replacement MicroTouch transaction.

For FVN, the central analytical question is not whether the trust earns interest; it is whether the sponsor can convert a finite-life cash vehicle into a completed, adequately financed operating company.

How is the MicroTouch transaction structured?

On January 16, 2026, FVN, its merger subsidiary and MicroTouch Technology entered into a merger agreement under which MicroTouch would survive as a wholly owned subsidiary. The public company would be renamed MicroTouch Inc. or another approved name. According to the official January 2026 Form 8-K, MicroTouch was assigned a $90 million enterprise value on a fully diluted basis, with consideration shares calculated using the SPAC redemption price capped at $10.05 per share.

Proposed target value
$90.0M
Enterprise value stated in the January 2026 merger announcement.
Share-pricing cap
$10.05
Maximum per-share redemption price used in the consideration calculation.
Net tangible asset condition
$5.0M+
Purchaser must have at least $5,000,001 immediately after closing.

What conditions still separate signing from closing?

The transaction remains conditional on shareholder approvals, effectiveness of the proxy/registration statement, absence of legal restraints, accuracy of representations and warranties, covenant compliance and delivery of closing certificates. MicroTouch shareholders entered into a transaction support agreement to vote for the merger, but that support does not eliminate public-shareholder redemptions, SEC review, Nasdaq requirements or other closing conditions.

Condition Current relevance What researchers should verify
Shareholder approval Required for the business combination Vote date, quorum, approval thresholds and redemption elections.
Registration effectiveness SEC process must be completed Latest amendments, unresolved comments and final proxy/prospectus.
Minimum net tangible assets At least $5,000,001 after closing Effect of redemptions, transaction costs and financing proceeds.
Listing compliance Nasdaq holder requirement was deficient in May 2026 Remediation plan and status before closing.
Outside date SPAC deadline currently September 13, 2026 Any additional extension vote, funding or amended merger deadline.

Who controls FVN, and why does governance matter?

FVN’s sponsor, HWei Super Speed Co. Ltd., acquired 1,437,500 founder shares for $25,000 before the IPO. The sponsor also purchased 299,000 private placement units for $2.99 million. Founder shares represented 20% of the company’s issued and outstanding shares immediately after the IPO, excluding the economic effect of later rights and other securities. This structure creates a strong incentive to complete a transaction because founder securities can lose substantial value if the SPAC liquidates.

Holder or security Amount Source period Governance implication
Sponsor founder shares 1,437,500 Issued February 2024 Sponsor has strong influence and merger-completion incentives.
Private placement units 299,000 at $10.00 each September 2024 IPO closing Additional sponsor capital is exposed to transaction outcome.
Public redeemable shares 5,750,000 March 31, 2026 Public holders can reduce deal cash through redemption.
Representative shares 57,500 issued September 2024 IPO closing Underwriter economics add another non-public stakeholder group.

How do voting rights differ?

Before the initial business combination, founder-share holders have the exclusive right to appoint directors and may remove directors by majority vote. In a vote to continue the company outside the Cayman Islands, founder shares carry ten votes each while ordinary shares carry one vote each. The sponsor has also agreed to vote its founder shares, private placement shares and any purchased public shares in favor of the initial business combination. These provisions mean economic ownership, redemption rights and governance influence are not perfectly aligned.

Public-holder redemption protectionStrong contractual right
Sponsor alignment with completionMixed
Dispersed public governance influenceLimited pre-close

What gives FVN an advantage, and where is the moat weak?

A SPAC does not possess a conventional moat based on brand, patents, network effects or recurring customer relationships. FVN’s potential advantage lies in transaction execution: sponsor sourcing, access to a public listing, a funded trust account, the ability to offer shares as merger consideration and a structure that may provide a private company with a faster or more negotiated route to public markets than a traditional IPO.

Capital already raised
$61.76M in trust at March 31, 2026 provides a defined funding pool, subject to redemptions and costs.
Negotiated transaction format
The merger agreement can specify valuation, governance, lock-ups and closing conditions.
Public listing pathway
Nasdaq listing can be transferred to the combined company if all conditions are satisfied.
Weak durability
These advantages expire if deadlines, approvals, financing or listing requirements are not met.

Who are the real competitors?

FVN competes with other SPAC sponsors, private equity firms, strategic acquirers, venture investors and traditional IPO underwriters for attractive targets. Rivalry is intense because many acquisition vehicles can offer similar capital and listing mechanics. Target companies also have bargaining power: they can reject valuation terms, seek private financing, pursue a strategic sale or wait for better market conditions. FVN’s terminated VIWO agreement illustrates the fragility of exclusivity and the cost of delay.

Alternative Advantage versus FVN FVN counter-position
Traditional IPO Broader price discovery and institutional marketing Negotiated valuation and merger terms can offer more certainty.
Private equity Operational expertise and committed private capital FVN offers a path to public equity and listed liquidity.
Strategic buyer Synergies and operating integration A merger with FVN can preserve target independence.
Other SPACs Potentially larger trusts or stronger sponsor networks FVN’s current MicroTouch agreement creates transaction-specific exclusivity.

What risks could change FVN’s outcome?

The most material risks are transaction completion, redemptions, deadline pressure, sponsor conflicts, target-company quality and continued listing. These are interdependent. High redemptions can reduce cash available at closing; lower cash can threaten minimum net tangible assets or require additional financing; financing can dilute shareholders; and delay can trigger more extension fees or liquidation.

September 13, 2026 deadline
Failure to complete a combination by the deadline can lead to mandatory redemption and liquidation.
Redemption rate
Every redeemed public share reduces cash delivered to the combined company.
Nasdaq round-lot holders
The May 5, 2026 notice cited noncompliance with the 300-holder requirement.
Extension financing
Each additional month requires a $191,475 trust deposit under the disclosed extension framework.
MicroTouch financial quality
Post-close value depends on target revenue, margins, cash flow and liabilities disclosed in the registration statement.
Dilution
Founder shares, private placement units, rights and new financing can reduce per-share ownership.

Why the Nasdaq notice matters

The March 2026 10-Q discloses that Nasdaq notified the company on May 5, 2026 that it no longer complied with Listing Rule 5550(a)(3), which requires at least 300 public holders. Listing deficiencies can often be cured, but the notice adds a separate execution track alongside the merger. Investors need to monitor whether FVN restores compliance, receives an extension or faces additional enforcement. The official Nasdaq listing page confirms the FVN trading symbol and exchange venue.

What does the going-concern warning mean?

Management concluded that the mandatory-liquidation requirement raises substantial doubt about the company’s ability to continue as a going concern. This is not a statement that the trust assets have disappeared. It reflects the legal design of a finite-life SPAC: if no transaction closes by the deadline, operations cease except for winding up, public shares are redeemed from the trust and the entity dissolves after settling obligations.

Which KPIs matter most for FVN?

Because FVN has no commercial operations, the relevant KPI dashboard is transaction-based. Researchers should focus on trust value, redemption exposure, time remaining, operating liquidity, deal conditions and target-company disclosures rather than sales growth or EBITDA.

KPI Current disclosed value How to interpret it
Trust assets $61.76M at March 31, 2026 Upper funding pool before redemptions, costs and permitted withdrawals.
Trust value per public share About $10.74 at March 31, 2026 Reference for redemption economics, calculated from disclosed figures.
Operating cash $873,737 at March 31, 2026 Liquidity available for expenses outside the restricted trust.
Quarterly cash burn $150,972 used in operations in Q1 2026 Indicates how quickly non-trust liquidity is consumed.
Extension cost $191,475 per month Incremental sponsor funding needed to keep the SPAC alive.
Public shares 5.75M at March 31, 2026 Denominator for potential redemptions and trust value per share.
Target enterprise value $90.0M announced January 2026 Starting point for evaluating consideration and post-close valuation.

What should the next filing add?

The most decision-useful document is the definitive proxy statement/prospectus or latest registration-statement amendment for the MicroTouch merger. It should provide audited target financial statements, revenue composition, margins, customer concentration, indebtedness, pro forma capitalization, share-count reconciliation, dilution, management biographies and detailed risk factors. Until those disclosures are current and effective, a DCF of the post-merger business would rest on incomplete inputs.

RedemptionsTrust per sharePro forma sharesMicroTouch revenueMicroTouch marginsClosing cashNasdaq compliance

Why is FVN difficult to value with a conventional DCF?

A standalone DCF requires forecastable operating cash flows. FVN has none before a business combination. Its current value drivers are trust assets, redemption terms, completion probability, transaction expenses, dilution and the value of the proposed target. Therefore, an analyst should separate the vehicle from the potential post-merger company.

Pre-close vehicle
$61.8M trust
Analyze redemption value, deadline, cash burn, extensions and closing probability.
Post-close operating company
$90.0M target EV
Analyze MicroTouch revenue, margins, reinvestment, debt, dilution and terminal risk once disclosed.

What belongs in a transaction-adjusted valuation?

The first layer is the trust-backed redemption value. The second is the expected value of the merger, weighted by closing probability and adjusted for transaction costs, sponsor dilution, public rights, private placement securities and any financing. The third is the operating valuation of MicroTouch using audited historical results and a defendable forecast. A credible model also needs a fully diluted post-close share count, not only the headline $90 million enterprise value.

Pre-close valuation priority ranking
Trust and redemption economicsPrimary
Closing probability and timingHigh
Dilution and financingHigh
Target operating DCFData-dependent
The ranking is an analytical framework, not a market-price forecast: the operating DCF becomes decisive only after target financial statements and pro forma capitalization are complete.

What should students and investors monitor next?

The next phase of the FVN story is event-driven. The following items can change the economic outcome more than quarter-to-quarter interest income.

Definitive merger materials
Confirm audited MicroTouch results, pro forma ownership and dilution.
Shareholder meeting date
Defines the approval and redemption timetable.
Redemption percentage
Determines how much trust cash remains for the combined company.
Additional financing
PIPE, debt or backstop terms may support closing but create dilution or leverage.
Extension actions
Watch each $191,475 monthly contribution and any new deadline vote.
Nasdaq remediation
Track compliance with the 300 round-lot-holder requirement.
Closing cash
Compare final cash to the $5,000,001 net-tangible-asset condition.
Post-close share count
Include founder shares, public shares, rights, private units and target consideration.

Which official filings are most useful?

The SEC filing record should remain the primary source. The latest quarterly report supplies trust, liquidity and deadline information; the annual report explains sponsor economics and the IPO structure; the merger 8-K supplies transaction terms; and later proxy/prospectus amendments should contain the target’s audited financial statements. FVN’s SEC EDGAR filing page is the most reliable place to monitor new submissions. The company’s official proxy statement and prospectus filing should be read together with subsequent amendments because transaction terms can evolve.

What is the key takeaway from FVN analysis?

Future Vision II Acquisition Corp. is not yet an operating company with a durable business model. It is a finite-life acquisition vehicle whose current balance sheet is dominated by $61.76 million of trust assets, whose pre-deal income comes from interest, and whose strategic value depends on completing the proposed MicroTouch transaction before the September 13, 2026 deadline.

Core conclusion: FVN’s strongest support is its trust-backed capital and shareholder redemption structure. Its main weakness is execution dependence: the prior VIWO deal failed, the MicroTouch transaction still requires approvals and effective registration, monthly extensions cost $191,475, and Nasdaq holder compliance remains an open issue. For research or valuation, the decisive next inputs are the target’s audited financials, the final redemption rate, closing cash, fully diluted share count and evidence that listing conditions can be satisfied. Until those facts are complete, FVN should be treated as a transaction with bounded trust value and substantial event risk—not as a mature operating franchise.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

(FVN) Future Vision II Acquisition Corp. Bundle

Get Full Bundle:
$17 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5